These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7466969)
1. [Neurotensin, a multi-action peptide hormone]. St-Pierre S; Quirion R; Regoli D; Gervais A; Lavigne F; Poirier A; Jolicoeur F; Barbeau A; Rioux F Union Med Can; 1980 Oct; 109(10):1447-55. PubMed ID: 7466969 [No Abstract] [Full Text] [Related]
2. [Pharmacological effects of neurotensin, substance P and tuftsin]. Herman ZS Postepy Biochem; 1985; 31(3-4):487-508. PubMed ID: 2430270 [No Abstract] [Full Text] [Related]
3. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human). Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970 [TBL] [Abstract][Full Text] [Related]
4. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide. Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological activities and side effects of plafibride. Gras J; Basi N; Zapatero J; Bermejo P; Gimenez F; Beascoa E; Llenas J; Bargalló MA; Giráldez A; Bruseghini L Arzneimittelforschung; 1981; 31(10a):1808-16. PubMed ID: 6976173 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of neurotensin analogues for structure/activity relationship studies. Acetyl-neurotensin-(8--13) is the shortest analogue with full binding and pharmacological activities. Granier C; van Rietschoten J; Kitabgi P; Poustis C; Freychet P Eur J Biochem; 1982 May; 124(1):117-24. PubMed ID: 7084220 [No Abstract] [Full Text] [Related]
7. General pharmacology studies on recombinant human follicle stimulating hormone. Biffoni M; Cantelmo A; Marcucci I; Martelli F; Suzuki H; Borrelli F; Suzuki K Arzneimittelforschung; 1994 Sep; 44(9):1096-102. PubMed ID: 7986251 [TBL] [Abstract][Full Text] [Related]
8. Highly potent neurotensin analog that causes hypothermia and antinociception. Tyler-McMahon BM; Stewart JA; Farinas F; McCormick DJ; Richelson E Eur J Pharmacol; 2000 Feb; 390(1-2):107-11. PubMed ID: 10708713 [TBL] [Abstract][Full Text] [Related]
9. [The effect of neurotensin on the cardiovascular system]. Osadchiĭ OE; Pokrovskiĭ VM Usp Fiziol Nauk; 1998; 29(2):39-54. PubMed ID: 9659683 [TBL] [Abstract][Full Text] [Related]
10. In vivo behavioral effects of stable, receptor-selective neurotensin[8-13] analogues that cross the blood-brain barrier. Kokko KP; Hadden MK; Price KL; Orwig KS; See RE; Dix TA Neuropharmacology; 2005 Mar; 48(3):417-25. PubMed ID: 15721174 [TBL] [Abstract][Full Text] [Related]
11. General pharmacology of recombinant human basic fibroblast growth factor. Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346 [TBL] [Abstract][Full Text] [Related]
12. Studies on neurotensin as a hormone. Assay and release of neurotensin-like immunoreactivity and effects of neurotensin. Rökaeus A Acta Physiol Scand Suppl; 1981; 501():1-62. PubMed ID: 6954834 [No Abstract] [Full Text] [Related]
13. General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2- piperidine ethanol. Terai T; Kusunoki T; Kita Y; Yoshida K; Akahane A; Shiokawa Y; Kohno Y; Horiai H; Mori J; Mine Y; Kohsaka M Arzneimittelforschung; 1996 Feb; 46(2):185-91. PubMed ID: 8720311 [TBL] [Abstract][Full Text] [Related]
14. Biologically active substituted benzodiazepines and their effect on cardiovascular and central nervous system. Shukla S; Misra U; Bhalla M; Mukerjee D; Saxena AK; Sinha JN; Shanker K Boll Chim Farm; 2001; 140(1):53-8. PubMed ID: 11338779 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues. Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636 [TBL] [Abstract][Full Text] [Related]
16. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys. Fantegrossi WE; Ko MC; Woods JH; Richelson E Pharmacol Biochem Behav; 2005 Feb; 80(2):341-9. PubMed ID: 15680187 [TBL] [Abstract][Full Text] [Related]
17. General pharmacological profile of the new cognition-enhancing agent nefiracetam. Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of the cardiovascular effects of neurotensin. Rioux F; Kérouac R; Quirion R; St-Pierre S Ann N Y Acad Sci; 1982; 400():56-74. PubMed ID: 6963116 [No Abstract] [Full Text] [Related]
19. [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance]. Hoefke W; Kobinger W Arzneimittelforschung; 1966 Aug; 16(8):1038-50. PubMed ID: 6014885 [No Abstract] [Full Text] [Related]
20. Pharmacological effects of N-cyclohexyl-N-methyl-(2-amino-3, 5-dibrombenzyl)-ammonium chloride (Bisolvon) with special reference to its expectorant action. Shimamoto K; Honjo T Acta Sch Med Univ Kioto; 1967 Jul; 40(1):98-118. PubMed ID: 5591497 [No Abstract] [Full Text] [Related] [Next] [New Search]